Stock T14 TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.

Equities

T14

CNE100000924

Pharmaceuticals

Market Closed - Singapore S.E.
Other stock markets
 04:59:06 2024-04-19 am EDT 		5-day change 1st Jan Change
1.99 USD 0.00% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.97% -3.86%
Apr. 02 Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5% MT
Mar. 29 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Number of employees: 4,619

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Patent Medicine
71.0 %
5,652 68.5 % 5,836 71.0 % +3.26%
Western Medicine
20.6 %
1,783 21.6 % 1,697 20.6 % -4.84%
Other
8.2 %
796 9.7 % 673 8.2 % -15.47%
Other Business
0.2 %
18 0.2 % 16 0.2 % -9.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.5 %
8,198 99.6 % 8,161 99.5 % -0.44%
Overseas
0.5 %
34 0.4 % 45 0.5 % +33.00%

Managers

Managers TitleAgeSince
Lei Wang CEO
 Chief Executive Officer 53 22-08-21
Hong Zhou CTO
 Chief Tech/Sci/R&D Officer 54 12-11-30
Xiu Mei Guo
42 -
Mai Wang
54 -
YU Zhang
51 -
Xi Xie
- -
Jian Zhang
61 -
Yan Jiao SEC
 Corporate Secretary 48 99-06-30

Members of the board

Members of the board TitleAgeSince
Ping Zhang BRD
 Director/Board Member 55 19-09-29
Yoke Pheng Liew BRD
 Director/Board Member 68 20-06-04
Hong Zhou CTO
 Chief Tech/Sci/R&D Officer 54 12-11-30
Jian Hua Xing BRD
 Director/Board Member 53 21-12-09
Mai Wang BRD
 Director/Board Member 54 17-07-31
Xiu Mei Guo BRD
 Director/Board Member 42 18-12-23
Yuan Xi Wang CHM
 Chairman 46 19-12-01
Li Qing BRD
 Director/Board Member 57 21-05-16
Min Guo BRD
 Director/Board Member 53 21-09-05
Ming Rui Zhang CHM
 Chairman 49 21-12-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,000,000 0 0 31.08 %
Stock B 1 571,443,476 239,803,030 ( 41.96 %) 1,285,200 ( 0.2249 %)

Shareholders

NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
58.52 %
331,120,528 58.52 % 1 278 M $
Zhong Ou Asset Management Co., Ltd
3.180 %
17,994,995 3.180 % 69 M $
Fullgoal Fund Management Co., Ltd.
1.543 %
8,732,919 1.543 % 34 M $
First Seafront Fund Management Co., Ltd.
1.505 %
8,514,173 1.505 % 33 M $
GF Fund Management Co., Ltd.
1.193 %
6,749,997 1.193 % 26 M $
Cinda Fund Management Co. Ltd.
0.6761 %
3,825,856 0.6761 % 15 M $
Swee Teck Michael Tan
0.6539 %
3,700,000 0.6539 % 14 M $
ABC-CA Fund Management Co., Ltd.
0.5240 %
2,965,400 0.5240 % 11 M $
Hotland Innovation Asset Management Co. Ltd.
0.4672 %
2,643,883 0.4672 % 10 M $
ICBC Credit Suisse Asset Management Co., Ltd.
0.4171 %
2,360,278 0.4171 % 9 M $
NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
2.633 %
5,265,000 2.633 % 11 M $
Value Partners Ltd.
0.2860 %
572,000 0.2860 % 1 M $
Amundi Ireland Ltd. (United Kingdom)
0.2330 %
465,900 0.2330 % 936 459 $
APS Asset Management Pte Ltd.
0.0932 %
186,400 0.0932 % 374 664 $
RAM Active Investments SA
0.0923 %
184,500 0.0923 % 370 845 $
Edmond de Rothschild (Europe) SA
0.0419 %
83,766 0.0419 % 168 370 $
BNY Mellon Investment Management Japan Ltd.
0.0350 %
70,000 0.0350 % 140 700 $

Company contact information

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

No. 17 Baidi Road Nankai District

300193, Tianjin

+

http://www.jydrt.com.cn/
address Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(T14)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
33.12 CNY
Average target price
45.8 CNY
Spread / Average Target
+38.29%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+40.86% 6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-16.30% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.93% 3.17B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-1.70% 2.57B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+37.23% 1.8B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-12.78% 1.62B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+1.02% 1.56B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+36.02% 1.29B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. T14 Stock
  5. Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited